The categories of cutaneous mosaicism: A proposed classification

American Journal of Medical Genetics, Part A

Volumn 170, Issue 2, 2016, Pages 452-459

  Happle, Rudolf ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cutaneous mosaicism; Didymosis; Disseminated mosaicism; Epigenetic mosaicism; Functional autosomal mosaicism; Functional X chromosome mosaicism; Nonsegmental mosaicism; Patchy mosaicism without midline separation; Revertant mosaicism; Segmental mosaicism of lethal autosomal mutations; Single point mosaicism; Superimposed segmental mosaicism of polygenic skin disorders; Twin spotting; Type 1 segmental mosaicism of autosomal dominant skin disorders; Type 2 segmental mosaicism of autosomal dominant skin disorders

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; AUTOSOMAL DOMINANT DISORDER; AUTOSOME MOSAICISM; BENIGN SKIN TUMOR; DIDYMOSIS; DISSEMINATED MOSAICISM; EPIDERMOLYSIS BULLOSA; EPIGENETIC MOSAICISM; GENOMIC MOSAICISM; HETEROZYGOSITY; HUMAN; HYPOHIDROTIC ECTODERMAL DYSPLASIA; INCONTINENTIA PIGMENTI; MOSAICISM; MULTIPLE CANCER; NEUROFIBROMATOSIS; NONHUMAN; NONSEGMENTAL MOSAICISM; PATCHY MOSAICISM WITHOUT MIDLINE SEPARATION; PIGMENTED NEVUS; PRIORITY JOURNAL; PSORIASIS; REVERTANT MOSAICISM; SEGMENTAL MOSAICISM; SEX CHROMOSOME MOSAICISM; SINGLE POINT MOSAICISM; SKIN CANCER; SKIN DISEASE; CLASSIFICATION; GENETICS; MALE; PATHOLOGY;

HUMANS; MALE; MOSAICISM; SKIN DISEASES, GENETIC;

EID: 84956739194     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.37439     Document Type: Article

References (75)

1. Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, McCarthy S, Fantin VR, Straley KS, Lobo S, Aston W, Green CL, Gale RE, Tirabosco R, Futreal A, Campbell P, Presneau N, Flanagan AM. 2011. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 43:1262-1265.
2. Au KS, Hebert AA, Roach ES, Northrup H. 1999. Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am J Hum Genet 65:1790-1795.
3. Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, Jones C, Hansen J, Blair E, Hofmann B, Siebert R, Turner G, Evans DG, Schrander-Stumpel C, Beemer FA, van Den Ouweland A, Halley D, Delpech B, Cleveland MG, Leigh I, Leisti J, Rasmussen S. 2000. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25:160-165.
4. Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E. 2007. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 39:1120-1126.
5. Caux F, Plauchu H, Chibon F, Faivre L, Fain O, Vabres P, Bonnet F, Selma ZB, Laroche L, Gérard M, Longy M. 2007. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur J Hum Genet 15:767-773.
6. Chernosky ME, Anderson DE, Chang JP, Shaw MW, Romsdahl MM. 1971. Familial progressive hyperpigmentation. Arch Dermatol 103:581-591.
7. Chess A. 2012. Mechanisms and consequences of widespread random monoallelic expression. Nat Rev Genet 13:421-428.
8. Chmara M, Wernstedt A, Wasag B, Peeters H, Renard M, Beert E, Brems H, Giner T, Bieber I, Hamm H, Sciot R, Wimmer K, Legius E. 2013. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency. Genes Chromosomes Cancer 52:656-664.
9. Choate KA, Lu Y, Zhou J, Choi M, Elias PM, Farhi A, Nelson-Williams C, Crumrine D, Williams ML, Nopper AJ, Bree A, Milstone LM, Lifton RP. 2010. Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science 330:94-97.
10. Choate KA, Lu Y, Zhou J, Elias PM, Zaidi S, Paller AS, Farhi A, Nelson-Williams C, Crumrine D, Milstone LM, Lifton RP. 2015. Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti. J Clin Invest 125:1703-1707.
11. Cohen MM Jr. 2007. Hemangiomas: Their uses and abuses. Am J Med Genet A 143A:235-240.
12. Cohen MM Jr. 2008. Segmental hemangioma: The misuse of a term. Am J Med Genet A 146A:672-673.
13. Colman SD, Williams CA, Wallace MR. 1995. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11:90-92.
14. Cram DL, Fukuyama K. 1974. Unilateral systematized hypochromic nevus. Arch Dermatol 109:416.
15. De Schepper S, Maertens O, Callens T, Naeyaert JM, Lambert J, Messiaen L. 2008. Somatic mutation analysis in NF1 café au lait spots reveals two NF1 hits in the melanocytes. J Invest Dermatol 128:1050-1053.
16. Fölster-Holst R, Nellen RG, Jensen JM, Poblete-Gutiérrez P, Steijlen PM, Schwarz T, Happle R, Van Geel M, Frank J. 2012. Molecular genetic support for the rule of dichotomy in type 2 segmental Darier disease. Br J Dermatol 166:464-466.
17. García-Vargas A, Hafner C, Pérez-Rodríguez AG, Rodríguez-Rojas LX, González-Esqueda P, Stoehr R, Hernández-Torres M, Happle R. 2008. An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation. Am J Med Genet A 146A:2275-2279.
18. Garcia-Linares C, Fernández-Rodríguez J, Terribas E, Mercadé J, Pros E, Benito L, Benavente Y, Capellà G, Ravella A, Blanco I, Kehrer-Sawatzki H, Lázaro C, Serra E. 2011. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH. Hum Mutat 32:78-90.
19. Gimelbrant A, Hutchinson J N, Thompson B R, Chess A. 2007. Widespread monoallelic expression on human autosomes. Science 318:1136-1140.
20. Griffin R, Binari R, Perrimon N. 2014. Genetic odyssey to generate marked clones in Drosophila mosaics. Proc Natl Acad Sci USA 111:4756-4763.
21. Groesser L, Herschberger E, Ruetten A, Ruivenkamp C, Lopriore E, Zutt M, Langmann T, Singer S, Klingseisen L, Schneider-Brachert W, Toll A, Real FX, Landthaler M, Hafner C. 2012. Postzygotic HRAS and KRAS mutations cause nevus sebaceus and Schimmelpenning syndrome. Nat Genet 44:783-787.
22. Groesser L, Herschberger E, Sagrera A, Shwayder T, Flux K, Ehmann L, Wollenberg A, Torrelo A, Bagazgoitia L, Diaz-Ley B, Tinschert S, Oschlies I, Singer S, Mickler M, Toll A, Landthaler M, Real FX, Hafner C. 2013. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol 133:1998-2003.
23. Hafner C, Toll A, Fernández-Casado A, Earl J, Marqués M, Acquadro F, Méndez-Pertuz M, Urioste M, Malats N, Burns JE, Knowles MA, Cigudosa JC, Hartmann A, Vogt T, Landthaler M, Pujol RM, Real FX. 2010. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci USA 107:20780-20785.
24. Hall JG. 1988. Review and hypotheses: Somatic mosaicism: Observations related to clinical genetics. Am J Hum Genet 43:355-363.
25. Happle R. 1995. What is a nevus? A proposed definition of a common medical term. Dermatology 191:1-5.
26. Happle R. 1999. Loss of heterozygosity in human skin. J Am Acad Dermatol 41:143-164.
27. Happle R. 2007a. Type 2 segmental Cowden disease vs. Proteus syndrome. Br J Dermatol 156:1089-1090.
28. Happle R. 2007b. Superimposed segmental manifestation of polygenic skin disorders. J Am Acad Dermatol 57:690-699.
29. Happle R. 2009. Monoallelic expression on autosomes may explain an unusual heritable form of pigmentary mosaicism: A historical case revisited. Clin Exp Dermatol 34:834-837.
30. Happle R. 2013. Phacomatosis pigmentokeratotica is a "pseudodidymosis". J Invest Dermatol 133:1923-1925.
31. Happle R. 2014. Mosaicism in human skin: Understanding nevi, nevoid skin disorders, and cutaneous neoplasia. Berlin: Springer.
32. Harrison BJ, Carpenter R. 1977. Somatic crossing-over in Antirrhinum majus. Heredity 38:169-189.
33. Horn D, Happle R, Neitzel H, Kunze J. 2002. Pigmentary mosaicism of the hyperpigmented type in two half-brothers. Am J Med Genet 112:65-69.
34. Jonkman MF, Scheffer H, Stulp R, Pas HH, Nijenhuis M, Heeres K, Owaribe K, Pulkkinen L, Uitto J. 1997. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 88:543-551.
35. Jonkman MF, Castellanos Nuijts M, van Essen AJ. 2003. Natural repair mechanisms in correcting pathogenic mutations in inherited skin disorders. Clin Exp Dermatol 28:625-631.
36. Kerns JA, Cargill EJ, Clark LA, Candille SI, Berryere TG, Olivier M, Lust G, Todhunter RJ, Schmutz SM, Murphy KE, Barsh GS. 2007. Linkage and segregation analysis of black and brindle coat color in domestic dogs. Genetics 176:1679-1689.
37. Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, Chalker J, McKenzie K, Abu-Amero S, Slater O, Chanudet E, Palmer R, Morrogh D, Stanier P, Healy E, Sebire NJ, Moore GE. 2013. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 133:2229-2236.
38. Kiritsi D, He Y, Pasmooij AM, Onder M, Happle R, Jonkman MF, Bruckner-Tuderman L, Has C. 2012. Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination. J Clin Invest 122:1742-1746.
39. Kiritsi D, Garcia M, Brander R, Has C, Meijer R, Jose Escámez M, Kohlhase J, van den Akker PC, Scheffer H, Jonkman MF, del Rio M, Bruckner-Tuderman L, Pasmooij AM. 2014. Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa. J Invest Dermatol 134:2097-2104.
40. Kiuru M, Launonen V, Hietala M, Aittomäki K, Vierimaa O, Salovaara R, Arola J, Pukkala E, Sistonen P, Herva R, Aaltonen LA. 2001. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol 159:825-829.
41. Kurek KC, Howard E, Tennant LB, Upton J, AlomariAI, Burrows PE, Chalache K, Harris DJ, Trenor CC 3rd, Eng C, Fishman SJ, Mulliken JB, Perez-Atayde AR, Kozakewich HP. 2012a. PTEN hamartoma of soft tissue: A distinctive lesion in PTEN syndromes. Am J Surg Pathol 36:671-687.
42. Kurek KC, Luks VL, Ayturk UM, Alomari AI, Fishman SJ, Spencer SA, Mulliken JB, Bowen ME, Yamamoto GL, Kozakewich HP, Warman ML. 2012b. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 90:1108-1115.
43. Lee N H, Choi E H, Choi W K, Lee S H, Ahn S K. 1999. Maffucci's syndrome with oral and intestinal haemangioma. Br J Dermatol 140:968-969.
44. Leonard N, Chaggar R, Jones C, Takahashi M, Nikitopoulou A, Lakhani SR. 2001. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours. J Clin Pathol 54:689-692.
45. Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, Peters K, Turner J, Cannons JL, Bick D, Blakemore L, Blumhorst C, Brockmann K, Calder P, Cherman N, Deardorff MA, Everman DB, Golas G, Greenstein RM, Kato BM, Keppler-Noreuil KM, Kuznetsov SA, Miyamoto RT, Newman K, Ng D, O'Brien K, Rothenberg S, Schwartzentruber DJ, Singhal V, Tirabosco R, Upton J, Wientroub S, Zackai EH, Hoag K, Whitewood-Neal T, Robey PG, Schwartzberg PL, Darling TN, Tosi LL, Mullikin JC, Biesecker LG. 2011. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 365:611-619.
46. Matt D, Xin H, Vortmeyer AO, Zhuang Z, Burg G, Böni R. 2000. Sporadic trichoepithelioma demonstrates deletions at 9q22.3. Arch Dermatol 136:657-660.
47. Montagna P, Procaccianti G, Galli G, Ripamonti L, Patrizi A, Baruzzi A. 1991. Familial hypomelanosis of Ito. Eur Neurol 31:345-347.
48. Niessen RC, Jonkman MF, Muis N, Hordijk R, van Essen AJ. 2005. Pigmentary mosaicism following the lines of Blaschko in a girl with a double aneuploidy mosaicism: (47, XX, +7/45, X). Am J Med Genet A 137A:313-322.
49. Online Mendelian Inheritance in Man (OMIM). Available from: http//www3.ncbi.nlm.nih.gov/Omim/ Accessed 3 Sept 2015 2015.
50. Overcash RT, Gibu CK, Jones MC, Ramos GA, Andreasen TS. 2015. Maternal and fetal capillary malformation-arteriovenous malformation (CM-AVM) due to a novel RASA1 mutation presenting with prenatal non-immune hydrops fetalis. Am J Med Genet A 167:2440-2443.
51. Paller AS, Syder AJ, Chan YM, Yu QC, Hutton E, Tadini G, Fuchs E. 1994. Genetic and clinical mosaicism in a type of epidermal nevus. N Engl J Med 331:1408-1415.
52. Pansuriya TC, van Eijk R, d'Adamo P, van Ruler MA, Kuijjer ML, Oosting J, Cleton-Jansen AM, van Oosterwijk JG, Verbeke SL, Meijer D, van Wezel T, Nord KH, Sangiorgi L, Toker B, Liegl-Atzwanger B, San-Julian M, Sciot R, Limaye N, Kindblom LG, Daugaard S, Godfraind C, Boon LM, Vikkula M, Kurek KC, Szuhai K, French PJ, Bovée JV. 2011. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet 43:1256-1261.
53. Pasmooij AM, Nijenhuis M, Brander R, Jonkman MF. 2012. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol 132:1374-1383.
54. Patterson JT. 1929. Somatic segregation produced by x-rays in Drosophila melanogaster. Proc Natl Acad Sci USA 16:109-111.
55. Peacock JD, Dykema KJ, Toriello HV, Mooney MR, Scholten DJ 2nd, Winn ME, Borgman A, Duesberry NS, Hiemenga JA, Liu C, Campbell S, Nickoloff BP, Williams BO, Steensma M. 2015. Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterations. Am J Med Genet A 167:1429-1435.
56. Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. 2013. Cowden syndrome and the PTEN hamartoma tumor syndrome: Systematic review and revised diagnostic criteria. J Natl Cancer Inst 105:1607-1616.
57. Poblete-Gutiérrez P, Wiederholt T, König A, Jugert FK, Marquardt Y, Rübben A, Merk HF, Happle R, Frank J. 2004. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest 114:1467-1474.
58. Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, Hammer F, Amor DJ, Irvine AD, Baselga E, Dompmartin A, Syed S, Martin-Santiago A, Ades L, Collins F, Smith J, Sandaradura S, Barrio VR, Burrows PE, Blei F, Cozzolino M, Brunetti-Pierri N, Vicente A, Abramowicz M, Désir J, Vilain C, Chung WK, Wilson A, Gardiner CA, Dwight Y, Lord DJ, Fishman L, Cytrynbaum C, Chamlin S, Ghali F, Gilaberte Y, Joss S, Boente Mdel C, Léauté-Labrèze C, Delrue MA, Bayliss S, Martorell L, González-Enseñat MA, Mazereeuw-Hautier J, O'Donnell B, Bessis D, Pyeritz RE, Salhi A, Tan OT, Wargon O, Mulliken JB, Vikkula M. 2013. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat 34:1632-1641.
59. Rivière JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, St-Onge J, Schwartzentruber JA, Gripp KW, Nikkel SM, Worthylake T, Sullivan CT, Ward TR, Butler HE, Kramer NA, Albrecht B, Armour CM, Armstrong L, Caluseriu O, Cytrynbaum C, Drolet BA, Innes AM, Lauzon JL, Lin AE, Mancini GM, Meschino WS, Reggin JD, Saggar AK, Lerman-Sagie T, Uyanik G, Weksberg R, Zirn B, Beaulieu CL, Majewski J, Bulman DE, O'Driscoll M, Shendure J, Graham JM Jr, Boycott KM, Dobyns WB. 2012. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 44:934-940.
60. Roh MR, Eliades P, Gupta S, Tsao H. 2015. Genetics of melanocytic nevi. Pigment Cell Melanoma Res. doi: 10.1111/pcmr.12412
61. Ross AL, Sanchez MI, Grichnik JM. 2011. Molecular nevogenesis. Dermatol Res Pract. Article ID 463184. doi: 10.1155/2011/463184
62. Rubin MB. 1972. Incontinentia pigmenti achromians: Multiple cases within a family. Arch Dermatol 105:424-425.
63. Sado T, Brockdorff N. 2013. Advances in understanding chromosome silencing by the long non-coding RNA Xist. Philos Trans R Soc Lond B Biol Sci 368:20110325.
64. Schwindinger WF, Francomano CA, Levine MA. 1992. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152-5156.
65. Sepp T, Yates JR, Green AJ. 1996. Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 33:962-964.
66. Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B, North PE, Marchuk DA, ComiAM, Pevsner J. 2013. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971-1979.
67. Smith FJ, Morley SM, McLean WH. 2004. Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex. J Invest Dermatol 122:73-77.
68. Steinmann K, Kluwe L, Friedrich RE, Mautner VF, Cooper DN, Kehrer-Sawatzki H. 2009. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas. J Invest Dermatol 129:615-621.
69. Stern C. 1936. Somatic segregation in Drosophila melanogaster. Genetics 21:625-730.
70. Torrelo A, Hernández-Martín A, Bueno E, Colmenero I, Rivera I, Requena L, Happle R, González-Sarmiento R. 2013. Molecular evidence of type 2 mosaicism in Gorlin syndrome. Br J Dermatol 169:1342-1345.
71. Vig BK. 1973. Somatic crossing over in Glycine Max (L.) Merrill: Effect of some inhibitors of DNA synthesis on the induction of somatic crossing over and point mutations. Genetics 73:583-596.
72. Wei J, Freytag M, Schober Y, Nockher WA, Mautner VF, Friedrich RE, Manley PW, Kluwe L, Kurtz A. 2014. Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo. PLoS ONE 9:107760.
73. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. 1991. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New Eng J Med 325:1688-1695.
74. Weitz NA, Lauren CT, Behr GG, Wu JK, Kandel JJ, Meyers PM, Sultan S, Anyane-Yeboa K, Morel KD, Garzon MC. 2015. Clinical spectrum of capillary malformation-arteriovenous malformation syndrome presenting to a pediatric dermatology practice: A retrospective study. Pediatr Dermatol 32:76-84.
75. Zweier C, Kraus C, Brueton L, Cole T, Degenhardt F, Engels H, Gillessen-Kaesbach G, Graul-Neumann L, Horn D, Hoyer J, Just W, Rauch A, Reis A, Wollnik B, Zeschnigk M, Lüdecke HJ, Wieczorek D. 2013. A new face of Borjeson-Forssman-Lehmann syndrome? De novo mutations in PHF6 in seven females with a distinct phenotype. J Med Genet 50:838-847.